Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Methyl gallate
Cat. No.:
0225LY-1324
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Methyl gallate is a reverse transcriptase inhibitor that provides antioxidant and anti-HIV-1 enzymatic inhibition activities.
Synonym:
NSC 363001; Gallicin; Gallic acid methyl ester; Gallincin; 99-24-1; Methyl 3,4,5-trihydroxybenzoate; Methylgallate; Benzoic acid, 3,4,5-trihydroxy-, methyl ester; Gallic acid, methyl ester; 3,4,5-Trihydroxy-benzoic acid methyl ester; 3,4,5-Trihydroxybenzoic acid methyl ester
CAS No.:
99-24-1
Compound CID:
7428
Formula:
C8H8O5
Formula Weight:
184.15
Specification
Relative Density:
1.501 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Methyl gallate can be used in antioxidant research to study the protection of cells from oxidative stress and its potential antimicrobial activity.
Library Information
Target:
Reverse transcriptase; HIV protease
Receptor:
Reverse transcriptase; HIV protease
Pathways:
Metabolism; Microbiology/Virology; NF-κB; Immunology/Inflammation; Proteases/Proteasome
Plate Number:
AOCL-17
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 271.52 mM
